Earnings History Data for Johnson & Johnson (JNJ) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Johnson & Johnson

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
15-10-2024	PM		JNJ	Johnson & Johnson	386,390	2.42	2.19	2.66	Johnson & Johnson Non-GAAP EPS of $2.42 beats by $0.21, revenue of $22.5B beats by $330M [10/15/2024 6:21 AM]	164.21	2.61 (1.62%)	160.60	-1.00 (-0.62%)	143.13 - 168.85	7,638,507	5,030,000	374,273
Johnson & Johnson declares $1.24 dividend [10/15/2024 6:31 AM] Johnson & Johnson in charts: Innovative Medicine recorded highest sales in Q3 [10/15/2024 6:37 AM] Earnings Snapshot: Johnson & Johnson tops Q3 estimates as Darzalex sales surge; raises FY24 sales outlook [10/15/2024 6:39 AM] Johnson & Johnson posts Q3 beat; lowers earnings guidance amid M&A impact [10/15/2024 8:53 AM] JNJ releases positive data on nipocalimab for myasthenia gravis in adolescents [10/15/2024 1:09 PM] How to play biotech stocks: Johnson & Johnson, Pfizer [Oct-14-24 05:32PM] Bank of America, Q3 earnings, Fedspeak: What to Watch [Oct-14-24 05:15PM] More Patients On Eli Lilly's Mirikizumab Achieved Histologic Response At One Year Compared To Johnson & Johnson's Drug [Oct-14-24 10:49AM] Is Johnson & Johnson (JNJ) Stock Set for Further Gains? [Oct-14-24 08:27AM] J&J, Abbott and Intuitive kick off latest medtech earnings season [Oct-14-24 06:00AM] Johnson & Johnson Reports Q3 2024 Results [2024-10-15 06:20AM] Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2024 [2024-10-15 06:25AM] J&J lifts profit and sales forecasts, beats Wall Street expectations [2024-10-15 06:22AM] Johnson & Johnson: Q3 Earnings Snapshot [2024-10-15 06:32AM] Johnson & Johnson Earnings Top; Dow Giant Works Toward Buy Point [2024-10-15 07:15AM] Johnson & Johnson reports Q3 beat, raises sales guidance [2024-10-15 07:11AM] J&J Reports Strong Earnings but Talc Worries Remain. The Stock Rises. [2024-10-15 06:28AM] Johnson & Johnson's Q3 Earnings: Revenue And EPS Beat On Strong Cancer Drug Sales, Revises Annual Outlook To Reflect V-Wave Acquisition [2024-10-15 08:20AM] Johnson & Johnson Earnings Top; Dow Giant Falls Amid Lowered Outlook [2024-10-15 08:03AM] Invest with Confidence: Intrinsic Value Unveiled of Johnson & Johnson [2024-10-15 08:00AM] Nipocalimab demonstrates sustained disease control in adolescents living with generalized myasthenia gravis in Phase 2/3 study [2024-10-15 08:00AM] J&J Reports Strong Earnings but Talc Worries Remain. The Stock Falls. [2024-10-15 08:09AM] Johnson & Johnson (JNJ) Tops Q3 Earnings and Revenue Estimates [2024-10-15 07:35AM] Johnson & Johnson Posts Weaker-Than-Expected Profit on Billions in Legal Costs [2024-10-15 10:09AM] J&J Stock Leapfrogs 50-Day Line After Health Care Titan Raises Sales Outlook [2024-10-15 10:25AM] J&J Reports Strong Earnings, Grapples with Ongoing Legal Challenges [2024-10-15 10:56AM] J&J Earnings Beat Expectations, Aided by Prescription-Drug Sales [2024-10-15 09:41AM] Johnson & Johnson (JNJ) Reports Q3 Earnings: What Key Metrics Have to Say [2024-10-15 09:30AM] Johnson & Johnson Stock Rises on Better-Than-Expected Revenue, Adjusted Profit [2024-10-15 10:09AM] This is the 3-point checklist for healthcare earnings: Strategist [2024-10-15 12:46PM] Stocks to Watch Tuesday: J&J, United Health, Apple, Walgreens [2024-10-15 11:07AM] Jim Cramer Says Is It The Beginning Of The End Of Johnson & Johnson (JNJ)s Multi-Year Legal overhang? Could Be [2024-10-15 01:39PM] Johnson & Johnson (JNJ) Q3 2024 Earnings Call Transcript [2024-10-15 02:30PM] Analyst Report: Johnson & Johnson [2024-10-15 11:39AM]
17-07-2024	PM		JNJ	Johnson & Johnson	359,170	2.82	2.71	2.80	Johnson & Johnson Non-GAAP EPS of $2.82 beats by $0.12, revenue of $22.4B beats by $60M [7/17/2024 6:22 AM]	156.34	5.33 (3.53%)	151.85	0.84 (0.56%)	143.13 - 175.97	11,135,944	5,570,000	165,178
Johnson & Johnson declares $1.24 dividend [7/17/2024 6:29 AM] Earnings Summary: Johnson & Johnson tops consensus in Q2, updates FY2024 outlook [7/17/2024 6:40 AM] Johnson & Johnson in charts: Innovative Medicine, MedTech and total U.S. sales highest in Q2 [7/17/2024 6:51 AM] J&J beats in Q2 as pharma segment outperforms [7/17/2024 9:52 AM] Big pharma rally after J&J earnings [7/17/2024 2:09 PM]
16-04-2024	PM		JNJ	Johnson & Johnson	355,340	2.71	2.64	2.68	JNJ Q1 earnings preview: A lot of moving factors expected to bring in-line results [4/15/2024 1:49 PM]	144.93	-2.66 (-1.81%)	145.09	-2.50 (-1.69%)	143.39 - 175.97	9,576,037	7,080,000	113,579
JNJ Q1 earnings preview: A lot of moving factors expected to bring in-line results [4/15/2024 1:49 PM] Johnson & Johnson Non-GAAP EPS of $2.71 beats by $0.06, revenue of $21.4B in-line [4/16/2024 6:21 AM] Johnson & Johnson in charts: Q1 Y/Y revenue growth slows across all categories [4/16/2024 6:46 AM] Johnson & Johnson raises dividend by 4% to $1.24 [4/16/2024 6:44 AM] J&J sets guidance below consensus as MedTech underperforms [4/16/2024 7:20 AM]
23-01-2024	PM		JNJ	Johnson & Johnson	388,080	2.29	2.27	2.35	Johnson & Johnson beats top and bottom line estimates; reaffirms FY24 outlook [1/23/2024 6:24 AM]	159.84	-2.62 (-1.62%)	159.28	-3.19 (-1.96%)	144.95 - 175.97	7,706,969	5,860,000	64,861
Johnson & Johnson in charts: MedTech segment sales surged 13% Y/Y in Q4 [1/23/2024 6:41 AM] Johnson & Johnson posts Q4 beat as pharma and MedTech outperform [1/23/2024 7:08 AM] Johnson & Johnson wins arbitration appeal against Genmab [1/23/2024 7:56 AM] Johnson & Johnson’s MedTech performance augurs well for industry: analysts [1/23/2024 12:23 PM] J&J may pay $700M to settle state AG probe into talcum powder marketing [1/23/2024 12:29 PM]
17-10-2023	PM		JNJ	Johnson & Johnson	406,300	2.66	2.52	2.55	Johnson & Johnson Non-GAAP EPS of $2.66 beats by $0.14, revenue of $21.35B beats by $300M [10/17/2023 6:21 AM]	155.82	-1.71 (-1.08%)	156.24	-1.29 (-0.82%)	150.11 - 181.04	10,111,016	5,670,000	211,779
Johnson & Johnson powers to Q3 beat as pharma outperforms [10/17/2023 7:11 AM] Johnson & Johnson in charts: Sales grow Y/Y for both major segments [10/17/2023 7:35 AM] 5 stocks to watch on Tuesday: J&J, Bank of America, United Airlines and more [10/17/2023 9:15 AM] Johnson & Johnson sees GLP-1 impact on weight loss surgeries [10/17/2023 12:08 PM] J&J lung cancer drug combo had superior progression-free survival in study [10/17/2023 3:00 PM]
20-07-2023	PM		JNJ	Johnson & Johnson	413,380	2.80	2.61	2.59	Johnson & Johnson Non-GAAP EPS of $2.80 beats by $0.18, revenue of $25.53B beats by $860M [7/20/2023 6:25 AM]	168.23	9.49 (5.98%)	161.55	2.81 (1.77%)	150.11 - 181.04	19,052,079	6,370,000	360,290
J&J looks to continue long streak of EPS beats with Q2 results [7/19/2023 1:35 PM] Johnson & Johnson Non-GAAP EPS of $2.80 beats by $0.18, revenue of $25.53B beats by $860M [7/20/2023 6:25 AM] Johnson & Johnson posts Q2 beat as Pharma, MedTech outperform [7/20/2023 7:07 AM] Biggest stock movers today: Netflix, American Airlines, Johnson & Johnson and more [7/20/2023 10:48 AM]
18-04-2023	PM	6:25 AM ET (Apr 18)	JNJ	Johnson & Johnson	517,390	2.68	2.51	2.67	Johnson & Johnson Non-GAAP EPS of $2.68 beats by $0.18, revenue of $24.7B beats by $1.09B, raises FY23 guidance [4/18/2023 6:22 AM]	161.03	-4.63 (-2.80%)	165.34	-0.33 (-0.20%)	150.11 - 186.69	12,512,529	7,940,000	272,774
Johnson & Johnson Q1 2023 Earnings Preview [4/17/2023 1:27 PM] Johnson & Johnson Non-GAAP EPS of $2.68 beats by $0.18, revenue of $24.7B beats by $1.09B, raises FY23 guidance [4/18/2023 6:22 AM] Johnson & Johnson lifts dividend by 5.3% to $1.19/share [4/18/2023 6:44 AM] J&J stock pops as Q1 revenue boosted by Darzalex, COVID vaccine; raises FY23 outlook [4/18/2023 7:18 AM]
24-01-2023	PM	6:25 AM ET (Jan 24)	JNJ	Johnson & Johnson	441,170	2.35	2.22	2.13	Johnson & Johnson Non-GAAP EPS of $2.35 beats by $0.11, revenue of $23.7B misses by $200M [1/24/2023 6:26 AM]	168.32	0.01 (0.01%)	167.40	-0.91 (-0.54%)	155.72 - 186.69	8,756,017	6,690,000	373,322
Johnson & Johnson to report Q4 earnings amid macro concerns [1/23/2023 12:05 PM] Morphic says Johnson & Johnson unit ended research collaboration [1/23/2023 7:15 AM] Johnson & Johnson Non-GAAP EPS of $2.35 beats by $0.11, revenue of $23.7B misses by $200M [1/24/2023 6:26 AM] J&J trades higher despite Q4 revenue hit by forex, COVID vaccine impact, FY23 outlook above estimates [1/24/2023 7:10 AM]
18-10-2022	PM	6:25 AM ET (Oct 18)	JNJ	Johnson & Johnson	434,209	2.55	2.49	0.00	Johnson & Johnson Non-GAAP EPS of $2.55 beats by $0.06, revenue of $23.8B beats by $360M [10/18/2022 6:27 AM]	165.95	-0.64 (-0.38%)	165.00	-1.59 (-0.95%)	155.72 - 186.69	8,365,384	5,780,000	362,576
Johnson & Johnson to report Q3 earnings amid macro concerns on guidance [10/17/2022 12:15 PM] Johnson & Johnson Non-GAAP EPS of $2.55 beats by $0.06, revenue of $23.8B beats by $360M [10/18/2022 6:27 AM] Johnson & Johnson lowers 2022 guidance amid inflationary and forex impact [10/18/2022 7:07 AM] Johnson & Johnson weighs job cuts ahead of consumer health spinoff [10/18/2022 12:09 PM] 11 Best Nano-Cap Stocks To Buy For 2022 [Oct-17-22 06:49PM] 11 Best Dividend Stocks to Buy According to Warren Buffett [Oct-17-22 04:34PM] Dow Futures Lift as Solid Earnings Boost Sentiment [Oct-17-22 03:14PM] Johnson & Johnson May Soon Need First Aid [Oct-17-22 02:10PM] 12 Best Undervalued Stocks To Buy Now [Oct-17-22 12:30PM] Johnson & Johnson, Netflix, Goldman Sachs Earnings: 3 Things to Watch [Oct-17-22 12:04PM] Moderna CEO talks competition with J&J, Novavax, AstraZeneca [Oct-17-22 11:09AM] Q3 Earnings Season to Gather Pace This Week [Oct-17-22 11:08AM] Pre-Markets Up to Start a New Week [Oct-17-22 10:33AM] 11 Best Dividend Aristocrats With Over 3% Yield [Oct-17-22 09:25AM] How to Find Strong Medical Stocks Slated for Positive Earnings Surprises [Oct-17-22 09:00AM] Is ALPS O'Shares U.S. Quality Dividend ETF (OUSA) a Strong ETF Right Now? [Oct-17-22 06:20AM] Stocks Power Higher, Goldman Sachs, J&J, Nordstrom And Netflix In Focus - Five Things To Know [Oct-18-22 05:07AM] Johnson & Johnson Reports Q3 2022 Results [Oct-18-22 06:25AM] Johnson & Johnson Tops Estimates but Trims Full-Year Sales Guidance. The Stock Is Rising. [Oct-18-22 06:50AM] Johnson & Johnson stock jumps toward 2-month high after profit, sales beat expectations [Oct-18-22 06:38AM] Johnson & Johnson Tops Q3 Earnings Forecast, Boosts 2022 Outlook On Pharma Strength [Oct-18-22 06:34AM] Johnson & Johnson Posts Higher Quarterly Sales Despite Strong Dollar [Oct-18-22 07:07AM] Johnson & Johnson Posts Higher Quarterly Sales, Profit Despite Strong Dollar [Oct-18-22 07:07AM] J&J results beat estimates on cancer drug strength [Oct-18-22 06:27AM] Dow Jones Futures Rally As Goldman, J&J Report Earnings; Netflix Earnings Due [Oct-18-22 08:25AM] J&J Leads Dow Jones Higher, but This Stock's an Even Bigger Winner [Oct-18-22 09:22AM] Johnson & Johnson Earnings Top Estimates. Its CFO Explains What Went Right. [Oct-18-22 09:07AM] Dow Jones Futures Surge 600 Points As Goldman, J&J Report Earnings; Netflix Earnings Due [Oct-18-22 08:59AM] Johnson & Johnson Notches Quarterly Beat, Outplaying Exchange-Rate Headwinds [Oct-18-22 08:49AM] Johnson & Johnson Likely to Make Some Cuts to Workforce Despite Higher Sales, Profit [Oct-18-22 08:43AM] Johnson & Johnson (JNJ) Tops Q3 Earnings and Revenue Estimates [Oct-18-22 07:45AM] Stocks Power Higher, Goldman Sachs, J&J, Nordstrom, Netflix in Focus - Five Things To Know [Oct-18-22 05:07AM] Dow Jones Surges 600 Points As Goldman, J&J Report Earnings; Netflix Earnings Due [Oct-18-22 09:42AM] Johnson & Johnson reports earnings beat, lower full-year guidance [Oct-18-22 09:59AM] UPDATE 4-J&J looks at job cuts despite weathering inflation impact [Oct-18-22 06:36AM] J&J Profit, Sales Beat While Currency Hit Weighs on Outlook [Oct-18-22 09:40AM] Johnson & Johnson beat on Q3 earnings despite inflationary pressures [Oct-18-22 11:44AM] Pre-Markets Rally on Q3 Beats from J&J, Goldman [Oct-18-22 10:20AM] 10 Best S&P 500 Stocks to Buy According to Hedge Funds [Oct-18-22 01:10PM] J&J (JNJ) Beats on Q3 Earnings, Cuts 2022 Sales View on Fx Woes [Oct-18-22 11:49AM] Pre-Markets in the Green on Strong Earnings Numbers [Oct-18-22 10:56AM] Johnson & Johnson Isnt Rushing into M&A [Oct-18-22 01:49PM] Johnson & Johnson Stock Can Fly if It Clears This Level [Oct-18-22 01:59PM] Johnson & Johnson Isnt Rushing Into M&A [Oct-18-22 01:49PM] Johnson & Johnson (JNJ) Q3 2022 Earnings Call Transcript [Oct-18-22 03:00PM]
19-07-2022	PM	6:25 AM ET (Jul 19)	JNJ	Johnson & Johnson	468,990	2.59	2.57	2.48	Johnson & Johnson Non-GAAP EPS of $2.59 beats by $0.04, revenue of $24B beats by $180M, cuts FY22 guidance [7/19/2022 6:26 AM]	171.72	-2.50 (-1.44%)	175.60	1.37 (0.79%)	155.72 - 186.69	11,057,411	5,290,000	98,020
J&J to report Q2 results amid several macro factors that threaten to diminish near-term growth [7/18/2022 12:34 PM] Johnson & Johnson beats on earnings, maintains FY22 Adj. op. EPS and op. sales, cuts FY22 revenue and Adj. EPS guidance [7/19/2022 6:26 AM] Johnson & Johnson cuts 2022 guidance as MedTech underperforms in 2Q [7/19/2022 7:00 AM] Johnson & Johnson's lowered guidance is a result of strong dollar - CFO [7/19/2022 8:06 AM]
19-04-2022	PM	6:25 AM ET (Apr 19)	JNJ	Johnson & Johnson	475,070	2.67	2.61	2.59	Johnson & Johnson Non-GAAP EPS of $2.67 beats by $0.10, revenue of $23.4B misses by $210M, reaffirms guidance [4/19/2022 6:26 AM]	182.98	5.32 (2.99%)	179.90	2.24 (1.26%)	155.72 - 185.94	11,665,543	6,920,000	244,699
J&J to report Q1 result amid lingering pandemic headwinds [4/18/2022 12:54 PM] Johnson & Johnson to pay $99M to resolve opioid suits with West Virginia [4/18/2022 9:42 AM] Johnson & Johnson raises dividend by 6.6% to $1.13 [4/19/2022 6:26 AM] Johnson & Johnson Non-GAAP EPS of $2.67 beats by $0.10, revenue of $23.4B misses by $210M [4/19/2022 6:26 AM] J&J stock rises on Q1 earnings beat; lowers adjusted EPS outlook, suspends COVID vaccine guidance [4/19/2022 7:27 AM] Johnson & Johnson set to report earnings on Tuesday morning [Apr-18-22 04:51PM] 5 Perfect Earnings Charts [Apr-18-22 03:54PM] Markets check: Stocks in the green, Treasury yields jump [Apr-18-22 03:16PM] The Safest Healthcare Stocks in the World [Apr-18-22 01:00PM] UPDATE 4-J&J settles West Virginia opioid litigation for $99 mln [Apr-18-22 09:12AM] J&J (JNJ) to Set the Tone for Pharma Sector's Q1 Earnings [Apr-18-22 09:06AM] J&J settles West Virginia opioid litigation for $99 million [Apr-18-22 09:00AM] Is Novavax Stock a Buy Now? [Apr-18-22 07:05AM] Tesla Earnings Follow Musk's Take-It-or-Leave-It Twitter Bid [Apr-18-22 06:33AM] U.S. stock futures advance as earnings season heats up [Apr-19-22 05:06AM] U.S. stock futures waver as earnings season heats up [Apr-19-22 05:37AM] Johnson & Johnson Announces Dividend Increase of 6.6% [Apr-19-22 06:20AM] J&J boosts dividend to lift implied yield to above 2.5% [Apr-19-22 06:26AM] Johnson & Johnson Reports Q1 2022 Results [Apr-19-22 06:25AM] J&J stock sinks after revenue misses and full-year outlook was cut, as drug sales disappoint [Apr-19-22 06:37AM] Johnson & Johnson Suspends Vaccine Sales Guidance, Cuts Profit Forecast; Stock Slumps [Apr-19-22 06:36AM] J&J suspends sales forecast for COVID-19 vaccine, cuts profit view [Apr-19-22 06:28AM] US STOCKS-Futures slip as bond yields hit new highs [Apr-19-22 07:16AM] Johnson & Johnson Reports Mixed Earnings and Cuts Guidance [Apr-19-22 07:40AM] Dow Jones Futures Rise Slightly As Earnings Season Continues; Netflix Earnings On Deck [Apr-19-22 08:04AM] J&J suspends sales forecast for COVID vaccine, cuts profit view [Apr-19-22 06:28AM] Dow Jones Futures Rise As Earnings Season Continues; Netflix Earnings On Deck [Apr-19-22 08:29AM] Johnson & Johnson Suspends Vaccine Sales Guidance, Cuts Profit Forecast; Stock Slips [Apr-19-22 09:04AM] Johnson & Johnson Cuts 2022 Outlook, Stops Giving Covid Shots Guidance [Apr-19-22 09:01AM] Earnings: Johnson & Johnson misses on revenue, suspends vaccine sales guidance [Apr-19-22 09:22AM] US STOCKS-Wall St set to open flat as bond yields hit new highs [Apr-19-22 09:12AM] Dow Jones Rises As Earnings Season Continues; Netflix Earnings On Deck [Apr-19-22 09:33AM] Johnson & Johnson (JNJ) Tops Q1 Earnings Estimates [Apr-19-22 07:45AM] Johnson & Johnson Suspends Vaccine Sales Guidance, Boosts Dividend; Stock Gains [Apr-19-22 09:36AM] Johnson & Johnson Suspends Vaccine Sales Guidance, Boosts Dividend; Stock Hits Record High [Apr-19-22 09:49AM] U.S. stocks edge mostly higher as earnings season heats up [Apr-19-22 09:46AM] Stock Market Up Nearly 1% As Earnings Pour In; These 2 Stocks Top Buy Points [Apr-19-22 10:30AM] Dow jumps 300 points as earnings season heats up [Apr-19-22 10:27AM] Amgen's (AMGN) Stelara Biosimilar Meets Psoriasis Study Goal [Apr-19-22 09:15AM] J&J Trims Annual Profit Forecast Citing Currency Headwinds [Apr-19-22 10:28AM] Experts dismayed by response to face mask mandate ruling as airlines immediately drop requirement in some cases mid-flight [Apr-19-22 10:39AM] Johnson & Johnson CFO: How inflation plays out is anybodys guess [Apr-19-22 10:46AM] Why J&J Is Shifting Its Focus From Covid Shots And Seeing A Stock Resurgence [Apr-19-22 11:00AM] US STOCKS-Earnings optimism helps Wall Street shrug off rising yields [Apr-19-22 10:58AM] Shareholders push for review of lobbying by Gilead, other drugmakers [Apr-19-22 10:57AM] Housing Market Remains Strong, Mortgage Rates To Rise [Apr-19-22 10:10AM] Experts dismayed by response to face-mask mandate ruling as airlines immediately drop requirement in some cases midflight [Apr-19-22 10:48AM] Is J&J Stock A Buy After Throwing Off The Covid Vaccine Shackles? [Apr-19-22 11:51AM] Stock Market Gains On Housing News, Lower Oil Prices; Positive Earnings Lift Stocks [Apr-19-22 12:25PM] Housing Data Up for March; JNJ, LMT Mixed in Q1 [Apr-19-22 10:36AM] US STOCKS-Wall Street climbs as earnings optimism overshadows rising yields [Apr-19-22 12:54PM] Medical-Device Stocks Surge Most Since 2020 After J&J Results [Apr-19-22 12:31PM] Dow Jones Jumps 400 Points, Led by Surging J&J Stock; Tech Stock Gives Rare Buy Signal [Apr-19-22 01:38PM] Dow jumps more than 350 points, U.S. stocks trade sharply higher as earnings season heats up [Apr-19-22 01:38PM] US STOCKS-Wall Street buoyant on earnings optimism, overshadows rising yields [Apr-19-22 02:06PM] Alabama reaches $276 million opioid settlement with J&J, McKesson, Endo -attorney general [Apr-19-22 02:05PM] Johnson & Johnson (JNJ) Q1 2022 Earnings Call Transcript [Apr-19-22 02:30PM] UPDATE 1-Alabama reaches $276 mln opioid settlement with J&J, McKesson, Endo -attorney general [Apr-19-22 02:21PM] UPDATE 2-Alabama reaches $276 mln opioid settlement with J&J, McKesson, Endo -attorney general [Apr-19-22 02:21PM] Dow jumps more than 400 points, U.S. stocks trade sharply higher as earnings season heats up [Apr-19-22 03:11PM] 'We always look at demand relative to our manufacturing capacity': J&J exec on COVID vaccine [Apr-19-22 03:46PM] UPDATE 3-Alabama reaches $276 mln opioid settlement with J&J, McKesson, Endo -attorney general [Apr-19-22 02:21PM] Why Johnson & Johnson Stock Rose Today [Apr-19-22 07:19PM] US STOCKS-Wall Street advances on earnings optimism, dovish rate rise remarks [Apr-19-22 04:47PM] Dow jumps nearly 500 points, U.S. stocks end sharply higher as earnings season heats up [Apr-19-22 04:36PM] Medical-Device Stocks Surge Most Since 2020 After J&J Report [Apr-19-22 04:07PM] US STOCKS-Wall Street ends higher as earnings optimism outshines rising yields [Apr-19-22 04:01PM] UPDATE 4-Alabama settles opioid claims with J&J, McKesson, Endo for $276 mln -attorney general [Apr-19-22 02:21PM] Alabama settles opioid claims with J&J, McKesson, Endo for $276 million -attorney general [Apr-19-22 02:05PM]
25-01-2022	PM	6:25 AM ET (Jan 25)	JNJ	Johnson & Johnson	434,040	2.13	2.12	1.86	Johnson & Johnson Non-GAAP EPS of $2.13 beats by $0.01, revenue of $24.8B misses by $490M [1/25/2022 6:31 AM]	167.74	4.77 (2.93%)	162.97	0.0 (0.00%)	151.47 - 179.92	10,220,240	8,060,000	55,222
Johnson & Johnson Non-GAAP EPS of $2.13 beats by $0.01, revenue of $24.8B misses by $490M [1/25/2022 6:31 AM] Johnson & Johnson down 2% on top-line miss; FY22 guidance tops consensus [1/25/2022 7:17 AM] OSHA withdraws private employee vaccine mandate following Supreme Court ruling [1/25/2022 12:21 PM] CBO report finds skyrocketing price increases for brand Rx drugs for Medicare, Medicaid [1/25/2022 1:17 PM] Biopharmas need to personalize engagement in competitive oncology landscape - Accenture [1/25/2022 1:50 PM] Hotaling Investment Management, LLC Buys Johnson & Johnson, Pfizer Inc, ON Semiconductor ... [Jan-24-22 09:38PM] Citizens & Northern Corp Buys AmerisourceBergen Corp, PPL Corp, Cisco Systems Inc, Sells ... [Jan-24-22 05:38PM] Stocks pare losses but hold lower ahead of earnings, Fed meeting [Jan-24-22 03:27PM] Websterrogers Financial Advisors, Llc Buys AvalonBay Communities Inc, Equity Residential, Essex ... [Jan-24-22 01:38PM] S.E.E.D. Planning Group LLC Buys Honeywell International Inc, Medtronic PLC, Johnson & ... [Jan-24-22 01:38PM] Keeler Thomas Management LLC Buys Amcor PLC, Amazon. ... [Jan-24-22 01:38PM] Microsoft, Johnson & Johnson, Verizon Earnings: 3 Things to Watch [Jan-24-22 10:44AM] UPDATE 2-Sinovac regimen gets strong boost from Pfizer, AstraZeneca or J&J COVID shots - study [Jan-24-22 10:01AM] 10 High Yield Dividend Kings for 2022 [Jan-24-22 09:56AM] Market Crash Predictions and 10 Stocks to Buy for Bad Times [Jan-24-22 08:58AM] Johnson & Johnson May Shed Some Tears in This Bear Market Decline [Jan-24-22 04:24AM] Johnson & Johnson Reports Q4 and Full-Year 2021 Results [Jan-25-22 06:25AM] J&J expects up to $3.5 billion in COVID vaccine sales this year [Jan-25-22 06:29AM] Johnson & Johnson Tops Q4 Earnings Forecast, Sees $3.5 Billion in 2022 Covid Vaccine Sales [Jan-25-22 01:41AM] J&J shares down 1.3% premarket after Q4 revenue lags consensus [Jan-25-22 06:45AM] Stock Market Today - 1/25: Dow Resume Slide With Fed, Earnings In Focus; General Electric, Johnson & Johnson, IBM Active [Jan-25-22 02:32AM] Those who invested in Johnson & Johnson (NYSE:JNJ) five years ago are up 64% [Jan-25-22 06:37AM] J&J expects COVID vaccine sales to jump as much as 46% in 2022 [Jan-25-22 06:29AM] SoftBank backs $140M round for biotech developing antibody nasal spray [Jan-25-22 08:34AM] US STOCKS-Futures tumble as tech selloff deepens; Fed meeting eyed [Jan-25-22 09:04AM] Johnson & Johnson Expects At Least $3 Billion In Sales Of Its Underdog Covid Shot [Jan-25-22 09:04AM] Stock Market Today - 1/25: Dow Resumes Slide With Fed, Earnings In Focus; General Electric, Johnson & Johnson, IBM Active [Jan-25-22 04:07AM] Johnson & Johnson (JNJ) Surpasses Q4 Earnings Estimates [Jan-25-22 07:55AM] Johnson & Johnson's FY21 COVID-19 Vaccine Sales Below Expectations [Jan-25-22 07:14AM] US STOCKS-Wall St slides over 2% as tech rout deepens; Fed meeting eyed [Jan-25-22 10:31AM] Market check: Stocks fall across the board, bitcoin rallies [Jan-25-22 11:20AM] Stock Gyrations Continue After Wild Day [Jan-25-22 11:31AM] Earnings: GE misses on revenue, JNJ posts mixed results, IBM tops estimates [Jan-25-22 12:01PM] Markets Await More Earnings Data [Jan-25-22 11:04AM] J&J (JNJ) Q4 Earnings Beat Estimates by a Penny, Sales Miss [Jan-25-22 10:52AM] Market Selling Resumes; GE, J&J Miss on Revenues [Jan-25-22 10:31AM] US STOCKS-Tech stocks drag Wall Street lower ahead of Fed meeting [Jan-25-22 01:01PM] Rhode Island, in reversal, to settle opioid claims against U.S. drug distributors [Jan-25-22 01:02PM] Dow Jones Fights As Fed Meeting Starts; Microsoft Dips Ahead Of Earnings; GE Stock Dives On This [Jan-25-22 03:15PM] RI gains $112M in opioid settlements with J&J and 3 drug distributors [Jan-25-22 02:39PM] Health at University of Alabama at Birmingham COVID-19 deaths: Vaccine misinformation is killing people, doctor says [Jan-25-22 03:29PM] Davis-Rea Ltd. Buys Raytheon Technologies Corp, Suncor Energy Inc, Sells Nike Inc, Algonquin ... [Jan-25-22 05:38PM] Coronavirus: We know that new variants will crop up, doctor says [Jan-25-22 04:56PM] COVID-19 deaths top 2,100 a day amid Omicron wave [Jan-25-22 04:43PM] Stock Market Today: Stocks End Down on Another Roller-Coaster Day [Jan-25-22 04:28PM] Why Johnson & Johnson Stock Rose Today [Jan-25-22 04:08PM] COVID-19 deaths: Vaccine misinformation is killing people, doctor says [Jan-25-22 03:29PM] Stock Market Today - 1/25: Nasdaq Falls 300 Points as Investors Consider Fed, Earnings [Jan-25-22 11:28AM]
19-10-2021	PM	6:25 AM ET (Oct 19)	JNJ	Johnson & Johnson	421,490	2.60	2.37	2.20	Johnson & Johnson EPS beats by $0.25, misses on revenue, boost FY21 guidance [10/19/2021 6:29 AM]	163.88	3.76 (2.35%)	160.93	0.81 (0.51%)	133.65 - 179.92	8,707,323	5,870,000	257,758
All eyes on Johnson & Johnson's Q3 results amid revenue growth slowdown concerns [10/18/2021 1:03 PM] FDA may authorize COVID vaccine 'mix and match' this week - NY Times [10/18/2021 9:07 PM] Johnson & Johnson EPS beats by $0.25, misses on revenue, boost FY21 guidance [10/19/2021 6:29 AM] Johnson & Johnson boosts FY guidance after Q3 profit beat [10/19/2021 6:50 AM] J&J CFO: Revenue miss was a matter of timing in vaccine, medical device businesses [10/19/2021 9:34 AM] Dow Jones Futures Fall As Stock Market Rally Strengthens: First Bitcoin ETF To Debut; Tesla Nears Record High [Oct-18-21 08:40PM] The Most Exciting Medical Breakthrough Of The Decade? [Oct-18-21 07:30PM] Markets Bounce Back on S&P 500, Nasdaq [Oct-18-21 06:10PM] Kevin OLeary sees trillions coming to crypto but he still loves these dividend stocks [Oct-18-21 04:48PM] US STOCKS-S&P, Nasdaq enjoy boost from big tech firms, Dow ends a hair lower [Oct-18-21 04:36PM] US STOCKS-Tech lifts S&P 500, Nasdaq amid inflation, China growth worries [Oct-18-21 12:36PM] U.S. may soon authorize boosters for all 3 in-use vaccines, as experts renew plea for unvaccinated to get their shots [Oct-18-21 12:07PM] J&J, Procter & Gamble, Netflix Earnings: 3 Things to Watch [Oct-18-21 11:43AM] Fauci Expects Regulators to Approve Mixing Vaccine Doses [Oct-18-21 11:03AM] Johnson & Johnson Named to the TIME100 Most Influential Companies List [Oct-18-21 11:01AM] J&J, Moderna COVID-19 Booster Jabs Near FDA Authorization [Oct-18-21 10:29AM] Profit-Taking to Start a New Trading Week [Oct-18-21 10:23AM] J&J (JNJ) to Start Q3 Earnings Season for Pharma Sector [Oct-18-21 09:59AM] Netflix earnings, Tesla earning, Airlines earnings what to expect [Oct-18-21 09:57AM] Retirement Stock Portfolio: 10 Safe Dividend Stocks To Consider [Oct-18-21 09:22AM] Johnson & Johnsons Booster Dose for COVID-19 Gets Green Light [Oct-18-21 09:03AM] Netflix, Tesla, Snap, Johnson & Johnson and Procter & Gamble are part of Zacks Earnings Preview [Oct-18-21 08:19AM] Wedbush: 'Bar is High' Ahead of Tesla (TSLA) Earnings [Oct-18-21 06:33AM] 2 Top Stocks for a Solid Portfolio Foundation [Oct-18-21 06:20AM] 2 Top Biotech Stocks to Buy in October [Oct-18-21 06:05AM] Forget FedEx: Here Are 3 Better Dividend Stocks [Oct-18-21 05:39AM] Here's How Johnson & Johnson Stock Looks Ahead of Earnings [Oct-18-21 04:44AM] 5 Stocks To Watch For October 18, 2021 [Oct-18-21 04:28AM] Dow Jones Futures Fall As Stock Market Rally Strengthens; 3 Tech Titans In New Buy Zones [Oct-18-21 09:04PM] Why Johnson & Johnson Will Be a Bigger Winner With Boosters Than Pfizer and Moderna [Oct-19-21 05:52AM] Coronavirus tally: Global cases of COVID-19 top 241 million and U.S. FDA may soon allow mix-and-match boosters [Oct-19-21 06:12AM] Johnson & Johnson Reports Q3 2021 Results [Oct-19-21 06:25AM] UPDATE 1-J&J raises 2021 profit view, keeps vaccine sales outlook unchanged [Oct-19-21 06:36AM] J&J raises 2021 profit view, keeps vaccine sales outlook unchanged [Oct-19-21 06:31AM] Johnson & Johnson Stock Gains As Vaccine Sales Boost Q3 Earnings, 2021 Forecasts [Oct-19-21 02:35AM] J&J beats profit estimates for latest quarter as sales fall short, raises guidance [Oct-19-21 06:44AM] Dow Jones Futures Rally 150 Points; 3 Tech Titans In New Buy Zones [Oct-19-21 06:55AM] J&J beats profit estimates for latest quarter as sales fall short and company raises full-year guidance [Oct-19-21 06:47AM] Johnson & Johnson Stock Is Rising Because Its Earnings Beat Trumps a Sales Miss [Oct-19-21 06:46AM] Johnson & Johnson May Not Have to Wait Long for Its Next Blockbuster Vaccine [Oct-19-21 07:00AM] Futures rise as upbeat earnings boost risk appetite [Oct-19-21 07:14AM] US STOCKS-Futures rise as upbeat earnings boost risk appetite [Oct-19-21 07:09AM] Dow Jones Futures Rally On Strong Earnings Results; 3 Tech Titans In New Buy Zones [Oct-19-21 07:34AM] J&J's COVID-19 shot generated $502 million in sales in the third quarter [Oct-19-21 07:33AM] Dow Jones Futures Rally As Bitcoin ETF Debuts; 4 Tech Stocks To Buy And Watch [Oct-19-21 08:20AM] Tuesday Could Be a Winning Market Day Despite Earnings Headwinds From These 2 Stocks [Oct-19-21 08:56AM] Johnson & Johnson (JNJ) Q3 Earnings Beat Estimates [Oct-19-21 07:45AM] US STOCKS-Earnings whip up risk appetite as Wall St sees higher open [Oct-19-21 09:08AM] Dow Jones Giant J&J Beats Profit Views As Covid Shot Brings In $502 Million [Oct-19-21 09:01AM] 10 Healthcare Stocks to Buy According to Billionaire Noam Gottesmans GLG Partners [Oct-19-21 08:58AM] Earnings whip up risk appetite as Wall St sees higher open [Oct-19-21 07:14AM] Procter & Gamble warns of price hikes, Vaccine sales boost Johnson & Johnson earnings [Oct-19-21 09:26AM] Dow Jones Rallies As Bitcoin ETF Debuts; 4 Tech Stocks To Buy And Watch [Oct-19-21 09:34AM] Dow rises tentatively and S&P 500 retakes 4,500 in early Tuesday trade [Oct-19-21 09:35AM] Johnson & Johnson Stock Is Soaring Because Earnings Beat, Raised Guidance [Oct-19-21 09:46AM] US STOCKS-Wall Street rises as earnings whip up risk appetite [Oct-19-21 10:16AM] Dow Jones Up 125 Points As These Key Stocks Rally On Earnings; Bitcoin ETF Launches [Oct-19-21 10:25AM] Dow Jones Giant J&J Calls For $2.5 Billion In Covid Vaccine Sales And Shares Pop [Oct-19-21 11:20AM] How Johnson & Johnsons vaccine meets the gold standard of the WHO [Oct-19-21 11:15AM] Home Building Data Disappoints [Oct-19-21 10:46AM] Home Building Disappoints Last Month; J&J and P&G Beat on Earnings [Oct-19-21 10:25AM] J&J (JNJ) Beats on Q3 Earnings, Misses on Sales, Ups EPS View [Oct-19-21 10:01AM] Dow Jones Rallies As J&J Leads Blue Chips; IPO Stock Breaks Out; Bitcoin ETF Debuts [Oct-19-21 12:10PM] 20 Safe Dividend Stocks to Quit Your 9 to 5 Job [Oct-19-21 12:31PM] Johnson & Johnson CFO talks earnings, vaccines [Oct-19-21 11:15AM] Mid-Morning Market Update: Markets Open Higher; Johnson & Johnson Boosts FY21 Guidance [Oct-19-21 10:08AM] J&J Wants Talc Suits Put on Hold After Units Bankruptcy Filing [Oct-19-21 01:06PM] Dow Jones Gains As Apple Pops; Biden Makes Spending Move; Bitcoin ETF Jumps On Debut [Oct-19-21 02:03PM] Johnson & Johnson (JNJ) Q3 2021 Earnings Call Transcript [Oct-19-21 02:00PM] Is J&J Stock A Buy On Its Bullish 2021 Covid Vaccine Sales Projection? [Oct-19-21 02:11PM] Why Johnson & Johnson Shares Are Trading Higher Today [Oct-19-21 11:13AM] J&J Wants Talc Suits On Hold After Units Bankruptcy Filing [Oct-19-21 02:34PM] Mid-Day Market Update: Silver Surges 3%; Galera Therapeutics Shares Plunge [Oct-19-21 12:11PM] How innovations in Covid-19 testing will play a part in this winter season [Oct-19-21 03:35PM] Why Johnson & Johnson Shares Trounced the Market Today [Oct-19-21 04:54PM] Dow Jones, Nasdaq Rally As Yields Also Climb; Netflix Scores Earnings Beat [Oct-19-21 04:28PM] 3 Biopharma Stocks To Watch Following Johnson & Johnson's Earnings Beat [Oct-19-21 03:10PM] Mid-Afternoon Market Update: Dow Surges Over 100 Points; Harmony Biosciences Shares Spike Higher [Oct-19-21 02:35PM] E-mini S&P 500 Index (ES) Futures Technical Analysis Charts Show No Major Resistance Until 4539.50 [Oct-19-21 03:11PM]
21-07-2021	PM	6:30 AM ET (Jul 21)	JNJ	Johnson & Johnson	439,460	2.48	2.28	1.67	Johnson & Johnson EPS beats by $0.19, beats on revenue [7/21/2021 6:31 AM]	169.46	1.02 (0.60%)	169.00	0.55 (0.33%)	133.65 - 173.65	6,060,319	6,750,000	57,777
Johnson & Johnson EPS beats by $0.19, beats on revenue [7/21/2021 6:31 AM] Johnson & Johnson boosts 2021 guidance after Q2 earnings beat [7/21/2021 7:16 AM] Johnson & Johnson expects $2.5B sales from COVID-19 shot in 2021 [7/21/2021 10:20 AM] Johnson & Johnson, drug distributors enter $26B opioid settlement [7/21/2021 3:05 PM] Drug Distributors Reach $1.2 Billion Opioid Settlement with New York State [Jul-20-21 07:10PM] Stock market news live updates: Futures inch higher after big rally, COVID remains focus [Jul-20-21 06:13PM] J&J Shot Is Less Effective Against Delta Variant Vs. Original Strain: New Study [Jul-20-21 05:56PM] Stock market news live updates: Stocks claw back prior days losses, post gains of nearly 2% in bargain-hunting rally as COVID fears wane [Jul-20-21 05:09PM] Drug Stocks Pop On Reports Of $26 Billion Settlement In Opioid Fight [Jul-20-21 04:05PM] JNJ Option Traders Ready for Positive Earnings [Jul-20-21 02:53PM] Likelihood of reaching herd immunity at this point is fairly low: Epidemiologist [Jul-20-21 02:51PM] 10 Cheap Monthly Dividend Stocks to Buy Now [Jul-20-21 10:38AM] Opioid settlement nears $26 billion, Judge allows vaccine mandate at university, Israeli PM threatens Unilever [Jul-20-21 10:27AM] J&J, Distributors Near Final Opioid Deal Terms With States [Jul-20-21 09:41AM] Why Earnings Season Could Be Great for J&J (JNJ) [Jul-20-21 08:52AM] Have $1,000? 2 Stocks to Buy Before the Next Market Crash [Jul-20-21 07:11AM] Vaccine Makers Gain After Fox News Anchors Become Jab Supporters [Jul-20-21 07:06AM] Opioid Settlement Of $26B Between Drug Companies, States To Potentially Conclude This Week [Jul-20-21 06:31AM] Johnson & Johnson, 3 Drug Distributors Near $26B Opioid Accord [Jul-20-21 06:28AM] IBM, Apple and Halliburton Rise Premarket; PPG Falls [Jul-20-21 04:08AM] J&J, Drug Distributors Up As Opioid Case Nears $26 Billion Settlement [Jul-20-21 01:47AM] Drugmakers, pharmacies next targets for U.S. opioid settlements [Jul-21-21 06:00AM] Coronavirus tally: Global cases of COVID-19 top 191.4 million and study finds J&J vaccine less effective vs. delta variant [Jul-21-21 06:30AM] Johnson & Johnson Beats Earnings Forecast; Vaccine Sales Top $160 Million [Jul-21-21 02:37AM] Johnson & Johnson Earnings Beat Views, Dow Giant Raises Full-Year Guidance [Jul-21-21 06:37AM] Johnson & Johnson forecasts $2.5 billion in COVID-19 vaccine sales this year [Jul-21-21 06:35AM] Johnson & Johnson beats earnings estimates for Q2 and raises full-year guidance [Jul-21-21 06:45AM] UPDATE 1-Johnson & Johnson forecasts $2.5 bln in COVID-19 vaccine sales this year [Jul-21-21 06:41AM] J&J raises forecasts, estimates $2.5 billion in COVID-19 vaccine sales [Jul-21-21 06:53AM] UPDATE 2-J&J raises forecasts, estimates $2.5 bln in COVID-19 vaccine sales [Jul-21-21 06:41AM] J&J raises forecasts, estimates $2.5 billion in COVID-19 vaccine sales [Jul-21-21 06:35AM] Dow futures up 140 points as stocks aim to extend rebound [Jul-21-21 07:26AM] J&J Gains On Revising Guidance After Medical Devices Boost In Q2 [Jul-21-21 03:24AM] J&J raises revenue forecast, estimates $2.5 billion in COVID-19 vaccine sales [Jul-21-21 06:53AM] UPDATE 3-J&J raises revenue forecast, estimates $2.5 bln in COVID-19 vaccine sales [Jul-21-21 06:41AM] J&J raises revenue forecast, estimates $2.5 billion in COVID-19 vaccine sales [Jul-21-21 06:35AM] J&J Stock Rises on Earnings. Study Adds to Doubts Over Its Vaccines Efficacy. [Jul-21-21 08:22AM] Dow Jones Today, Futures Seek Balance After Rebound; Earnings Lift Chipotle, ASML Holdings; Will China Floods Hurt Apple? [Jul-21-21 08:17AM] Johnson & Johnson (JNJ) Q2 Earnings and Revenues Top Estimates [Jul-21-21 07:45AM] JNJ CFO: Were certain vaccine demand will increase [Jul-21-21 09:33AM] Dow opens higher as stocks extend rebound rally [Jul-21-21 09:47AM] Dow Jones Today Leads As Stocks Extend Rebound; Earnings Lift Chipotle, ASML Holdings; China Floods Weigh On Apple [Jul-21-21 08:43AM] Johnson & Johnson Shrugs Off Vaccine Worries But Stays Flat Despite Quarterly Beat [Jul-21-21 09:58AM] J&J Earnings Beat Expectations as Study Raises Doubts Over Vaccines Efficacy [Jul-21-21 09:55AM] Dow Jones Rallies As Netflix Slides On Earnings; Chipotle Surges On Earnings Beat [Jul-21-21 10:14AM] UPDATE 4-J&J forecasts $2.5 bln in COVID-19 vaccine sales this year [Jul-21-21 06:41AM] US STOCKS-Wall Street rises on upbeat earnings, recovery optimism [Jul-21-21 10:29AM] US STOCKS-Upbeat earnings, recovery optimism lift Wall St futures [Jul-21-21 07:22AM] J&J forecasts $2.5 billion in COVID-19 vaccine sales this year [Jul-21-21 06:53AM] Norway, Lithuania swap J&J, Pfizer vaccines to speed up inoculation [Jul-21-21 10:39AM] Delta variant of COVID is now in 124 countries and will likely be dominant strain globally within months, says WHO [Jul-21-21 10:38AM] Dow up more than 200 points as stocks extend rebound rally [Jul-21-21 11:08AM] Earnings Data Deluge [Jul-21-21 09:48AM] J&J COVID-19 vaccine sales to total $2.5 billion in 2021 [Jul-21-21 11:22AM] Delta variant of SARS-CoV-2 is now in 124 countries and will likely be dominant strain globally within months, says WHO [Jul-21-21 11:57AM] J&J CFO: Not-for-Profit Vaccine Price Likely to End in 2021 [Jul-21-21 11:26AM] Coke, J&J, Verizon All Beat on Q2 Numbers [Jul-21-21 10:24AM] U.S. Corporate Earnings Cast Off Covid Gloom With Rosy Outlooks [Jul-21-21 11:07AM] Delta variant of SARS-CoV-2 will likely be dominant strain globally within months after spreading to 124 countries, says WHO [Jul-21-21 01:21PM] Its very premature to talk about booster vaccines: Doctor [Jul-21-21 01:43PM] UPDATE 1-Drug distributors, J&J reach landmark $26 bln opioid settlement [Jul-21-21 02:16PM] J&J to stop selling opioids for 10 years and will pay $5 billion as part of settlement [Jul-21-21 02:27PM] UPDATE 2-Big 3 U.S. drug distributors, J&J reach landmark $26 bln opioid settlement [Jul-21-21 02:16PM] J&J Shrugs Off Vaccine Worries And Nabs Opioid Settlement Will Shares React? [Jul-21-21 02:35PM] Is JNJ Stock A Buy Or A Sell As Delta Question Plagues Covid Shot? [Jul-21-21 02:52PM] J&J, Distributors Reach Settlement With States Over Opioids [Jul-21-21 02:36PM] UPDATE 3-Big 3 U.S. drug distributors, J&J reach landmark $26 bln opioid settlement [Jul-21-21 02:16PM] States Unveil $26 Billion Settlement Over Opioid Lawsuits [Jul-21-21 03:37PM] South African company to start making Pfizer vaccine [Jul-21-21 07:48PM] Stock market news live updates: Futures gain after 2 day rally, eyes on jobless claims [Jul-21-21 06:13PM] J&J, Distributors Unveil $26 Billion Opioid Deal With States [Jul-21-21 04:56PM] Dow Jones Up 270 Points After Coca-Cola, Johnson & Johnson, Verizon Announce Earnings [Jul-21-21 04:44PM] Dow closes up more than 285 points as stocks extend rebound rally [Jul-21-21 04:36PM] Johnson & Johnson (JNJ) Q2 2021 Earnings Call Transcript [Jul-21-21 04:30PM] J&J Nabs $5 Billion Opioid Settlement And Beats Second-Quarter Views [Jul-21-21 04:25PM] Why Shares of Endo Pharamecuticals Are Soaring Today [Jul-21-21 03:54PM] UPDATE 4-State AGs urge support for landmark $26 bln opioid settlement [Jul-21-21 02:16PM]
20-04-2021	PM	6:40 AM ET (Apr 20)	JNJ	Johnson & Johnson	427,130	2.59	2.31	2.30	Johnson & Johnson EPS beats by $0.24, beats on revenue [4/20/2021 6:31 AM]	166.53	3.84 (2.36%)	161.30	-1.39 (-0.85%)	133.65 - 173.65	11,906,795	7,920,000	51,427
Johnson & Johnson hikes dividend by 5% to $1.06 per share [4/20/2021 6:48 AM] JNJ raises 2021 guidance and quarterly dividend after Q1 earnings beat consensus [4/20/2021 7:11 AM] JNJ COVID-19 vaccine: European Medicines Agency highlights positive benefit-risk [4/20/2021 10:35 AM] JNJ reiterates positive benefit/risk profile of COVID-19 vaccine as CDC probes a "handful" of more cases of adverse events [4/20/2021 11:41 AM] J&J to resume vaccine rollout in Europe following EMA review (updated) [4/20/2021 12:06 PM] Philippines approves emergency use of J&J, Bharat BiotechCOVID-19 vaccines [Apr-19-21 06:58PM] Emergent Factory Halt Adds to Obstacles for J&Js Covid Vaccine [Apr-19-21 06:19PM] UPDATE 5-J&J, other drugmakers go to trial in California in $50 bln case over 'deadly legacy' of opioids [Apr-19-21 06:05PM] Gold prices end lower after biggest weekly rise since December [Apr-19-21 02:06PM] What does a strong reaction to a COVID-19 vaccine mean? [Apr-19-21 02:04PM] Doctor on J&J vaccine: You have a much higher risk of getting a blood clot if you smoke [Apr-19-21 01:49PM] Emergent BioSolutions Stock Falls After FDA Initiates Inspection Of Bayview Facility [Apr-19-21 01:20PM] UPDATE 2-J&J COVID-19 vaccine reviewed for links to additional reports of severe side effects -CDC [Apr-19-21 12:30PM] Why Emergent BioSolutions Stock Is Tumbling Today [Apr-19-21 12:29PM] 2 Things Investors Need to Look For in Johnson & Johnson's Earnings Tomorrow [Apr-19-21 12:14PM] Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now [Apr-19-21 11:45AM] Doctor on J&J vaccine: It comes down to 'the benefit-risk ratio' [Apr-19-21 11:36AM] U.S. agency reviewing potential additional cases of severe side effects linked to J&J shot - CDC [Apr-19-21 10:57AM] South Africa's vaccine compensation fund could cost $17.5 mln in first year [Apr-19-21 10:55AM] U.S. COVID-19 vaccine program meets key goal, but India cases and Brazil deaths worry experts [Apr-19-21 10:09AM] U.S. hits vaccine milestone despite rise in COVID cases [Apr-19-21 09:31AM] Johnson & Johnson Reports Earnings Tuesday. Heres What to Expect. [Apr-19-21 09:12AM] The more we talk about it, the more were validating the symptoms: What we know about COVID vaccine side effects in women [Apr-19-21 09:10AM] What Does J&J's Pause Mean for Investors? [Apr-19-21 09:05AM] J&J, others face California trial over claims they fueled opioid epidemic [Apr-19-21 08:42AM] Should You Buy Johnson & Johnson (JNJ) Ahead of Earnings? [Apr-19-21 08:32AM] What to Know About Bitcoins Terrible Weekendand Dogecoins Wicked Rally [Apr-19-21 08:22AM] UPDATE 1-J&J, others face California trial over claims they fueled opioid epidemic [Apr-19-21 07:36AM] 5 Blue-Chip Stocks Likely to Gain on Q1 Earnings This Week [Apr-19-21 07:10AM] UPDATE 3-FDA asks Emergent plant behind botched COVID-19 vaccines to pause manufacturing [Apr-19-21 06:42AM] Emergent BioSolutions says it has agreed with FDA not to manufacture new material at Baltimore facility [Apr-19-21 06:42AM] J&J, other drugmakers to face trial in California over claims they fueled opioid epidemic [Apr-19-21 06:00AM] Johnson & Johnson Gains on Vaccine Commitment As FDA Moves on EBS [Apr-19-21 04:51AM] What determines when Americans reclaim their liberty? Here is Dr. Faucis answer [Apr-19-21 01:33AM] The publics expectation of perfection: Risk of blood clot from Johnson & Johnson COVID-19 vaccine is 0.00009% [Apr-19-21 01:28AM] Johnson & Johnson Earnings Preview: Heres What You Need To Know [Apr-20-21 04:37AM] 3 Dividend Aristocrats to Buy and Hold Forever [Apr-20-21 06:09AM] Johnson & Johnson Announces Dividend Increase of 5.0% [Apr-20-21 06:30AM] Johnson & Johnson Reports 2021 First-Quarter Results: [Apr-20-21 06:30AM] Johnson & Johnson to Host Earnings Call [Apr-20-21 06:30AM] J&J beats profit and sales expectations, boosts dividend; COVID-19 vaccine adds $100 million to sales [Apr-20-21 06:45AM] UPDATE 1-Johnson & Johnson's COVID-19 vaccine brings in $100 mln in quarterly sales [Apr-20-21 06:41AM] Johnson & Johnson's COVID-19 vaccine brings in $100 million in quarterly sales [Apr-20-21 06:37AM] Johnson & Johnson Tops Earnings Forecast, Boosts 2021 Guidance [Apr-20-21 02:38AM] UPDATE 1-J&J seeks approval to conduct local trial of its COVID-19 vaccine in India [Apr-20-21 06:57AM] UPDATE 2-J&J reports $100 mln in vaccine sales as results top forecasts [Apr-20-21 06:41AM] J&J reports $100 million in vaccine sales as results top forecasts [Apr-20-21 06:37AM] Johnson & Johnson Earnings Top, Dividend Hiked [Apr-20-21 07:17AM] Warren Buffett Owns These 5 Dividend Aristocrats. Should You? [Apr-20-21 08:12AM] Johnson & Johnson Just Reported Earnings. This Number Is Critical. [Apr-20-21 08:26AM] Pfizer (PFE)/ BioNTech to Supply Extra Comirnaty Doses to EU [Apr-20-21 07:50AM] UPDATE 3-J&J reports $100 mln in vaccine sales as results top forecasts [Apr-20-21 06:41AM] The Zacks Analyst Blog Highlights: Johnson & Johnson, Verizon, Dow, American Express and Honeywell [Apr-20-21 08:19AM] Johnson & Johnson (JNJ) Beats Q1 Earnings and Revenue Estimates [Apr-20-21 07:55AM] Johnson & Johnson CFO: COVID vaccine 'on track' after blood clot scare [Apr-20-21 09:35AM] How Johnson & Johnson Beat Expectations in Q1 [Apr-20-21 09:42AM] J&J stands ready to roll out COVID-19 vaccine in Europe [Apr-20-21 08:37AM] Dow Jones Falls As Apple Edged Up Ahead Of 'Spring Loaded' Event; Tesla Jumps On Price Target Boost [Apr-20-21 10:12AM] US STOCKS-S&P 500, Dow slip as focus turns to tech earnings [Apr-20-21 10:32AM] Johnson & Johnson vaccine should get blood-clot warning, European agency says [Apr-20-21 10:27AM] UPDATE 1-EU regulator finds possible link between J&J COVID-19 vaccine and blood clots [Apr-20-21 10:26AM] J&J (JNJ) Q1 Earnings Top, COVID-19 Vaccine Brings $100M Sales [Apr-20-21 09:46AM] Dow Jones Falls As Apple Reverses Ahead Of 'Spring Loaded' Event; Tesla Jumps On Price Target Boost [Apr-20-21 10:40AM] COVID vaccine 'on track' after blood clot scare: Johnson & Johnson CFO [Apr-20-21 10:33AM] Global tally of COVID-19 cases top 142 million as Indias surging cases raise the alarm [Apr-20-21 10:45AM] Global tally of COVID-19 cases top 142 million as Indias surge raises the alarm [Apr-20-21 11:02AM] UPDATE 2-EU regulator backs J&J vaccine despite finding possible link to blood clots [Apr-20-21 10:26AM] Dow Jones Sells Off As Apple Reverses Ahead Of 'Spring Loaded' Event; Tesla Jumps On Price Target Boost [Apr-20-21 11:16AM] European Health Regulators Add Blood Clot Warning to J&JS Covid-19 Vaccine [Apr-20-21 11:04AM] Dow Jones Sells Off As Apple Slides Ahead Of 'Spring Loaded' Event; Tesla Jumps On Price Target Boost [Apr-20-21 11:33AM] Bellwether J&J Squashes First-Quarter Views; Will Other Medical Stocks Follow? [Apr-20-21 11:32AM] Better-than-Expected Corporate Earnings [Apr-20-21 10:48AM] P&G, J&J Beat on Earnings, Drop in Pre-Market [Apr-20-21 10:31AM] J&J Signals Optimism With Covid Vaccine Use in Limbo in U.S. [Apr-20-21 11:26AM] UPDATE 3-EU regulator backs J&J shot, finds possible link to clots [Apr-20-21 10:26AM] Johnson & Johnson COVID-19 Vaccine Roll-out to Resume in Europe Following European Medicines Agency (EMA) Review [Apr-20-21 11:54AM] Johnson & Johnson (JNJ) Q1 2021 Earnings Call Transcript [Apr-20-21 12:00PM] Dow Jones Dives 300 Points Despite IBM, J&J Gains As Stock Market Gets Slammed [Apr-20-21 12:08PM] J&J to resume COVID-19 vaccine shipments to EU, with a warning 'very rare' adverse events [Apr-20-21 12:24PM] German scientist: J&J to cooperate in study of rare clots linked to COVID-19 vaccine [Apr-20-21 12:54PM] Netherlands to resume use of J&J COVID-19 vaccine, says health minister [Apr-20-21 01:15PM] Dow Jones Slumps 250 Points, But IBM Flashes Buy Signal; Leading Growth Stocks, Small Caps Crushed Again [Apr-20-21 01:34PM] Pandemic eviction bans found to protect entire communities from COVID-19: Study [Apr-20-21 02:15PM] Johnson & Johnson vaccine pause isnt crimping confidence in the vaccination process, survey says [Apr-20-21 02:47PM] Dow Jones Slumps 300 Points, But IBM Flashes Buy Signal; Apple Debuts New iMacs, iPad Pro Tablets [Apr-20-21 03:05PM] EMA Finds Potential Blood Clot Link With JNJ COVID-19 Shot, Adds Safety Warning [Apr-20-21 12:09PM] EU regulatory agency links J&J COVID-19 vaccine to rare blood clots [Apr-20-21 03:24PM] Dow Jones Loses Over 300 Points; These Blue Chips Score Breakouts On Earnings [Apr-20-21 03:15PM] Dow Jones Loses 300 Points; These Blue Chips Score Breakouts On Earnings [Apr-20-21 03:15PM] UPDATE 1-J&J to cooperate in study of rare clots linked to COVID-19 vaccine, German scientist says [Apr-20-21 03:35PM] Fauci: JNJ vaccine may return Friday with new limits [Apr-20-21 03:37PM] Dow Jones Futures: Market Retreat Slams Leaders; Netflix Dives Late On Subscriber Miss, But 3 Stocks Flash Buy Signals [Apr-20-21 07:47PM] Johnson & Johnson Rises on 1st-Quarter Earnings Beat [Apr-20-21 05:58PM] Covid-19 vaccines arent making any money for Johnson & Johnson [Apr-20-21 05:57PM] Key Decisions Coming on Products From Vertex, AstraZeneca and Other Pharmas [Apr-20-21 05:40PM] Dow Slides As Procter & Gamble Move Raises Inflation Fears; JNJ Rallies On Vaccine News [Apr-20-21 04:31PM] UPDATE 2-J&J to cooperate in study of rare clots linked to COVID-19 vaccine, German scientist says [Apr-20-21 03:35PM]
26-01-2021	PM	6:40 AM ET (Jan 26)	JNJ	Johnson & Johnson	430,550	1.86	1.81	1.88	Johnson & Johnson EPS beats by $0.03, beats on revenue, guides FY21 above consensus [1/26/2021 6:44 AM]	170.39	3.72 (2.66%)	169.75	3.77 (2.27%)	109.16 - 173.65	12,405,068	7,905,767	413,569
Johnson & Johnson EPS beats by $0.03, beats on revenue, guides FY21 above consensus [1/26/2021 6:44 AM] J&J tops Q4 forecast, guides FY2021 outlook above consensus [1/26/2021 7:11 AM] MeiraGTx's AAV-CNGA3 Fast Track'd in U.S. for inherited retinal disease [1/26/2021 8:53 AM] Johnson & Johnson expects to release COVID-19 vaccine results next week, CFO tells CNBC [1/26/2021 11:16 AM] JNJ earnings release brightens U.S. biopharma outlook - BofA [1/26/2021 12:38 PM] Companies beating estimates bodes well for the rest of earnings season: WealthWise Financial CEO [Jan-26-21 12:25PM] J&J Will Report on Covid-19 Vaccines Efficacy Within Days [Jan-26-21 12:23PM] US STOCKS-S&P 500 scales new high on upbeat corporate earnings [Jan-26-21 10:22AM] Dow Jones Today, Stocks Tick Higher As Earnings Lift J&J, 3M, GE; And Elon Musk Loves Etsy [Jan-26-21 09:55AM] Johnson Johnson Just Reported Earnings. Heres the One Number to Pay Attention To. [Jan-26-21 07:48AM] Johnson & Johnson to Host Earnings Call [Jan-26-21 06:30AM] Should You Buy Johnson & Johnson Stock Before Its Big Coronavirus Vaccine News? [Jan-26-21 06:09AM] Comic: Covid-19 in 2021: Déjà Vu, or the Beginning of the End? [Jan-25-21 11:16PM] Moderna CEO offers a bleak assessment of COVID-19: Virus to stay with the world 'forever' [Jan-25-21 05:46PM] Merck Scraps 'Inferior' Covid-19 Vaccines; But Shares Recover From Dip [Jan-25-21 04:38PM] Covid Vaccines: Here's What J&J Has To Do To Undercut Pfizer, Moderna [Jan-25-21 04:36PM] Dow Pares Big Loss, Nasdaq Hits New High As Apple Stock Rallies Ahead Of Earnings [Jan-25-21 04:35PM] It Was a Grim Morning in the Covid-19 Fight. The Market Is Looking to Johnson & Johnson for Hope. [Jan-25-21 03:17PM] The space is moving very quickly: MindMed Co-CEO on new psychedelic ETF [Jan-25-21 03:10PM] Humanigen signs manufacturing deal with Emergent for experimental COVID-19 drug [Jan-25-21 01:21PM] J&J may share findings from Phase 3 vaccine trial this week [Jan-25-21 12:37PM] University Hospital CEO on COVID-19 vaccination rollout [Jan-25-21 11:42AM] Coronavirus update: Moderna launches booster study for South African strain, Merck pulls out of vaccine race [Jan-25-21 11:21AM] Johnson & Johnson's Earnings: A Preview [Jan-25-21 10:03AM] COVID-19 Vaccine Update New Strains and Supply Issues Remain a Concern [Jan-25-21 02:00AM]
13-10-2020	PM	6:40 AM ET (Oct 13)	JNJ	Johnson & Johnson	397,480	2.20	1.98	2.12	Johnson & Johnson beats on earning, raises FY20 guidance [10/13/2020 6:41 AM]	148.56	-3.28 (-2.16%)	149.35	-2.49 (-1.64%)	109.16 - 157.00	9,273,268	5,965,703	270,334

16-07-2020	PM	6:30 AM ET (Jul 16)	JNJ	Johnson & Johnson	389,970	1.67	1.49	2.58	Johnson & Johnson EPS beats by $0.16, beats on revenue [7/16/2020 6:42 AM]	148.00	-0.26 (-0.18%)	148.67	0.41 (0.28%)	109.16 - 157.00	4,442,691	6,229,663	148,742